KV Pharmaceutical Company
Mallinckrodt Plc
Monsanto
Pfizer, Inc.
Sigma-Aldrich
University of Nebraska
There are more medicines and medical devices on the market today than at any other time and a record number in development. With hundreds of millions of dollars invested in researching and marketing each new drug and device, pharmaceutical companies need sophisticated legal guidance to manage their considerable risks. As drug companies and device manufacturers dedicate themselves to improving the quality of life for all patients, our firm has the practice depth and experience to protect their interests through every stage of that process.
Our representation of pharmaceutical manufacturers goes back more than 70 years, beginning with Pfizer and its predecessor companies. Because of this history, we have comprehensive knowledge of the regulations that affect the industry. In the last decade, pharmaceutical companies have chosen our attorneys to defend them in product liability litigation and class actions relating to vaccines, hormone replacement therapies, weight loss drugs, cancer treatment, rheumatoid arthritis treatment, medical devices, acetaminophen toxicity and in multidistrict VIOXX® litigation. We vigorously defend our pharmaceutical clients because we understand that maintaining the public trust in their medicines is a priority for the industry.
For pharmaceutical companies, safeguarding intellectual property is of paramount importance, and our firm has the capacity to meet their needs in this key area. Our IP attorneys have in-depth experience in the protection and management of intellectual property portfolios and in litigation. Likewise, our international commerce attorneys can assist pharmaceutical clients in working with Customs and Border Protection and the U.S. State Department to protect themselves against unregulated imports and counterfeit medicines entering the marketplace.
Our experience serving pharmaceutical companies extends to mergers and acquisitions, environmental litigation and Environmental Protection Agency (EPA) actions, and labor and employment matters. In addition, we provide advice to clients regarding antitrust issues and assist them in implementing antitrust compliance programs.
We have defended Pfizer, Inc., in multiple product liability suits alleging serious personal injury as a result of taking various hormone replacement therapy drugs.
We represented a pharmaceutical company in product liability litigation relating to the Thimerosal vaccine. This case was tried in Madison County, Ill., a notoriously plaintiff-friendly venue.
We have defended a multinational medical device, pharmaceutical and consumer packaged goods manufacturer in a putative class action regarding drug counterfeiting.
CIMA v. KV
Pharmaceutical
We represented the pharmaceutical manufacturer in this patent infringement case involving the composition of prescription drugs. With approximately $30 million at stake, we defended the preliminary injunction hearing which involved extensive Markman interpretation. The court entered a judgment in favor of our client on the motion for preliminary injunction.
We successfully challenged an EPA penalty levied against Archimica, Inc., a privately held pharmaceutical fine chemical company with seven manufacturing facilities in Italy, France, Germany, Great Britain and Springfield, Missouri. Our attorney demonstrated to EPA officials that several of the alleged violations were based on EPA's apparent misinterpretations of the applicable regulations. After a review of all the information submitted by Archimica and our arguments, the EPA reduced the penalty to a negligible amount.
Governor Pritzker signs bill expanding medical cannabis program
Missouri’s 2018 medical cannabis initiatives: Part 2 – Business
Missouri’s 2018 medical cannabis initiatives: Part 1 – The basics
Blog Browse: CBD drugs moved to Schedule 5; no promises for cannabis
CBD drugs moved to Schedule 5; no promises for cannabis
7 facts employers and employees should know about HIPAA and the opioid crisis
DOJ continues to investigate, seek recoveries over compounding pharmacy fraud
Blog Browse: National Right to Try Act passes U.S. House
National Right to Try Act passes U.S. House
FDA to step up enforcement of homeopathic medicine
Adopting a naloxone in the workplace program: What employers need to know
NAFTA, tariffs and trade wars: Are you ready to do battle in Missouri?
Participate in standard-setting bodies? The enforceability of your patents could be affected
Seven steps to avoid the new waves of Chinese tariffs on industrial goods
Supreme Court overturns the Federal Circuit, granting more flexibility to biosimilar makers
USPTO launches new proof of use audit program
5 tips for environmental due diligence in business transactions
D.C. appellate court strikes another nail in the coffin for the Frye test
Thompson Coburn Defends Monsanto in Upholding Trial Win
John Galvin Shares Insights on PFAS Lawsuits
ACI Drug and Medical Device Litigation Conference
Carl Pesce on Participation Rates in 3M Settlements
Suzanne Galvin Quoted in Bloomberg Law Regarding Revised PFAS Settlement
World Trademark Review names Tom Polcyn to WTR 1000 list
St. Louis litigators John Galvin, Suzanne Galvin join Thompson Coburn
Booker Shaw receives Distinguished Lawyer Award at 2019 Law Day celebration
Gain Executive Insights on trade developments with Thompson Coburn, Hispanic Chamber of Commerce
Thompson Coburn earns corporate counsel recommendations five years running in national report
Partner
|
New York
|
John draws on his more than 30 years of litigation experience to represent a wide variety of clients in federal and state trial and appellate courts. John draws on his more than 30 years of litigation experience to represent ... |
|
|||||
Partner
|
St. Louis
|
John represents domestic and international clients in complex litigation and multi-district litigation in some of the most challenging state and federal venues in the cou... John represents domestic and international clients in complex litigation an... |
|
|||||
Partner
|
St. Louis
|
Clients turn to Suzanne Galvin for results in complex high-profile litigation, particularly in the areas of pharmaceutical, medical device, and environmental exposure cla... Clients turn to Suzanne Galvin for results in complex high-profile litigati... |
|
|||||
Partner
|
St. Louis
|
Chris serves as Chair of Thompson Coburn, managing the 800+ person firm and leading the firm's executive and management committees in the execution of its strategic plan. Chris serves as Chair of Thompson Coburn, managing the 800+ person firm and... |
|
|||||
Partner
|
New York
|
James serves as legal adviser to investors, entrepreneurs, investment advisers and investment bankers as they fund or invest in new companies, grow established private co... James serves as legal adviser to investors, entrepreneurs, investment advis... |
|
|||||
Senior Counsel
|
St. Louis
|
Mike has extensive experience in complex litigation, including products liability, RICO, toxic tort claims, and contract disputes. Mike has extensive experience in complex litigation, including products lia... |
|
|||||
Partner
|
St. Louis
|
Manoo serves as a strategist for high-stakes litigation, tapping his well-honed research and writing skills to craft motions and briefs that help clients navigate thorny ... Manoo serves as a strategist for high-stakes litigation, tapping his well-h... |
|
|||||
Senior Counsel
|
St. Louis
|
Jack tries complex cases involving intellectual property, product liability and commercial issues before various state and federal courts. Jack tries complex cases involving intellectual property, product liability... |
|
|||||
Senior Counsel
|
St. Louis
|
Rick devotes his entire practice to the defense of employers in ERISA litigation related to pension, life, health, and disability benefits, both self-funded and insured. Rick devotes his entire practice to the defense of employers in ERISA litig... |
|
|||||
Partner
|
St. Louis
|
Carl has represented corporations in high-stakes litigation on a regional and national basis for more than 30 years. Carl has represented corporations in high-stakes litigation on a regional a... |
|
|||||
Partner
|
St. Louis
|
Carl is a trial lawyer who defends complex, high-profile cases. Carl is a trial lawyer who defends complex, high-profile cases. |
|
|||||
Partner
|
Washington, D.C.
|
Robert counsels clients in all aspects of international transactions with a focus on the trade and shipment of goods. Robert counsels clients in all aspects of international transactions with a... |
|
|||||
Partner
|
St. Louis
|
Retired Judge Booker Shaw is a skilled litigator and appellate advocate who brings valuable insight and perspective gained from his more than 25 years on the bench. Retired Judge Booker Shaw is a skilled litigator and appellate advocate who... |
|
|||||
Partner
|
St. Louis
|
Peter is an environmental attorney who helps companies respond to major environmental incidents, navigate regulatory actions and successfully resolve civil and criminal l... Peter is an environmental attorney who helps companies respond to major env... |
|
|||||
Partner
|
St. Louis
|
Dudley became the Firm's General Counsel in 2018. Dudley became the Firm's General Counsel in 2018. |
|
|||||
Partner
|
St. Louis
|
Jason is a dynamic and highly effective litigator who develops and executes creative solutions to resolve product liability, personal injury, and commercial disputes in s... Jason is a dynamic and highly effective litigator who develops and executes... |
|
NOTICE.
Although we would like to hear from you, we cannot represent you until we know that
doing so will not create a conflict of interest. Also, we cannot treat unsolicited
information as confidential. Accordingly, please do not send us any information
about any matter that may involve you until you receive a written statement from
us that we represent you (an ‘engagement letter’).
By clicking the ‘ACCEPT’ button, you agree that we may review any information you transmit to us. You recognize that our review of your information, even if you submitted it in a good faith effort to retain us, and, further, even if you consider it confidential, does not preclude us from representing another client directly adverse to you, even in a matter where that information could and will be used against you. Please click the ‘ACCEPT’ button if you understand and accept the foregoing statement and wish to proceed.